Small Molecule Drug Screening in Drosophila Identifies the 5HT2A Receptor As a Feeding Modulation Target.

Gabriel Gasque,Stephen Conway,Juan Huang,Yi Rao,Leslie B. Vosshall
DOI: https://doi.org/10.1038/srep02120
IF: 4.6
2013-01-01
Scientific Reports
Abstract:Dysregulation of eating behavior can lead to obesity, which affects 10% of the adult population worldwide and accounts for nearly 3 million deaths every year. Despite this burden on society, we currently lack effective pharmacological treatment options to regulate appetite. We used Drosophila melanogaster larvae to develop a high-throughput whole organism screen for drugs that modulate food intake. In a screen of 3630 small molecules, we identified the serotonin (5-hydroxytryptamine or 5-HT) receptor antagonist metitepine as a potent anorectic drug. Using cell-based assays we show that metitepine is an antagonist of all five Drosophila 5-HT receptors. We screened fly mutants for each of these receptors and found that serotonin receptor 5-HT2A is the sole molecular target for feeding inhibition by metitepine. These results highlight the conservation of molecular mechanisms controlling appetite and provide a method for unbiased whole-organism drug screens to identify novel drugs and molecular pathways modulating food intake.
What problem does this paper attempt to address?